How to Earn Your HIPAA Certification Online: A 2025 Beginner’s Guide

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Whether you’re new to healthcare, changing roles, or just looking to boost your resume, one credential stands out more than ever in 2025: HIPAA certification. And the good news? You can now earn it fully online, often in just a few hours – and sometimes for free. HIPAA, the Health Insurance Portability and Accountability Act, […]

The post How to Earn Your HIPAA Certification Online: A 2025 Beginner’s Guide appeared first on Medical News Bulletin.

Your Ultimate Evidence Backed Guide to iCBT

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Looking for information on iCBT? You are in the right place! Scenario: You’ve been given a referral for internet-based cognitive behavioural therapy instead of an in-person appointment with a therapist and you have questions. We get it! It’s not what you were expecting and you might be feeling unsure if it works or cautious about […]

The post Your Ultimate Evidence Backed Guide to iCBT appeared first on Medical News Bulletin.

FDA to act against use of GLP-1 active pharmaceutical ingredients in non-approved drugs

The FDA announced it planned to restrict use of GLP-1 active pharmaceutical ingredients in non-FDA-approved drugs, including those from Hims & Hers and other compounding pharmacies.
“These actions are aimed to safeguard consumers from drugs for which the FDA cannot verify quality, safety or efficacy,” Martin A. Makary, MD, MPH, FDA Commissioner, wrote in a press release.
The FDA also intends to act against direct-to-consumer advertising about non-FDA-approved compounded products.
“Companies cannot claim that non-FDA-approved compounded products are generic versions or the

Robotic-assisted pars repair may be safe, effective

Results showed robotic-assisted pars repair may be a safe and effective treatment option for adolescent athletes with symptomatic spondylolysis who failed nonoperative treatment.
“We have now, in the last several years, been increasingly offering [robotic-assisted pars repair] to our patients,” Sheeraz Qureshi, MD, MBA, co-chief of spine service and Patty and Jay Baker chair in minimally invasive spine surgery at Hospital for Special Surgery and professor of orthopedic surgery at Weill Cornell Medical College, told Healio. “It does not mean we jump the first nonsurgical

Proteomics play pivotal role in assessing impact of biological, chronological aging in MS

 
SAN DIEGO — For individuals with MS, proteomic analysis offers insight into the role disease progression plays in affecting both biological and chronological age progression as well as mortality risk, according to a speaker at ACTRIMS.
“We know that aging is the most important prognostic factor for MS because it drives the transition from relapsed-remaining MS to the progressive phase of MS,” Dylan Hamitouche, a doctoral student at McGill University and student researcher at Montreal Neurological Institute-Hospital, said during his presentation.
“We also know that aging alters the

‘TrumpRx’ website launches, but experts question how impactful it will be

President Donald J. Trump announced the launch of TrumpRx, the direct-to-consumer drug website that features reduced prices for dozens of medications.
The website “provides patients with access to a world-class experience for accessing deep discounts on the medicines they need,” according to a White House fact sheet.
Patients cannot buy drugs directly from TrumpRx. Instead, the site directs them to manufacturers’ own direct-to-consumer websites or offers coupons that patients can take to pharmacies.
According to the fact sheet, the website’s launch includes drugs made by the first five

Opioid use for corneal cross-linking: Potential concerns and drug stewardship

The ongoing opioid epidemic highlights health care’s role in fueling the crisis as well as the highly addictive nature of opioids.
Even a single exposure to opioids can increase the risk for dependence (Sun et al.; Thao et al.).
Although postoperative opioid prescriptions in ophthalmology are typically low dose and written without refills, the specialty is not spared from unintended harms. In one analysis, patients who received even a single opioid prescription after ophthalmic surgery had higher rates of hospitalization, overdose and mortality compared with those who did not, with risk

Pegcetacoplan slows GA progression with no change in vision loss

Pegcetacoplan injections slowed progression of geographic atrophy but had no impact on visual acuity in a real-world setting, according to a study published in Vision.
“GA and [neovascular age-related macular degeneration] often coexist in the same eye; approximately a quarter of all new diagnoses of nAMD have concurrent GA, and approximately 25% of GA cases without nAMD at baseline are diagnosed with nAMD within 3 years,” Jessica A. Cao, clinical research fellow at Retina Consultants of Texas, and colleagues wrote. “Therefore, there remains a major unmet need to better

How dermatologists can treat the aesthetic effects of GLP-1s

MIAMI BEACH, Fla. — As the use of GLP-1 receptor agonists continues to grow, dermatologists are increasingly likely to encounter patients seeking treatment for cutaneous adverse events, according to a presentation at South Beach Symposium.
GLP-1s are associated with metabolic improvements beyond weight loss, and emerging data suggest they may also improve other inflammatory conditions, including psoriasis and hidradenitis suppurativa. However, rapid weight loss with GLP-1s can cause aesthetic effects, including fat redistribution in the face and changes in skin integrity, Karan Lal, DO, MS,

CDC carries on without a permanent director

More than a year into the second Trump administration, the CDC is still operating without a permanent director — which, former CDC officials said, puts national health and safety at risk.
“This is dangerous,” Tom Frieden, MD, MPH, who served as CDC director during Barack Obama’s two-term presidency, told Healio. “Americans deserve health advice from health experts, not politicians and lawyers.”
For most of the past year, HHS Secretary Robert F. Kennedy Jr. (a lawyer), Jim O’Neill (a biotech investor) and CDC Chief of Staff Matthew Buzzelli (a lawyer) have made key decisions at the CDC that